ISRG vs BSX
ISRG and BSX side by side — valuation & fundamentals (public data).
Key statistics
| Metric | ISRGIntuitive Surgical, Inc. | BSXBOSTON SCIENTIFIC CORPORATION |
|---|---|---|
| Market cap | $134.63B | $64.14B |
| P/E (TTM) | 43.7 | 17.9 |
| P/B | 7.41 | 2.57 |
| P/S | 13.2x | 3.2x |
| Revenue | $11.03B(TTM) | $21.00B(TTM) |
| Revenue growth (YoY) | 20.5% | 19.9% |
| Net income | $3.14B(TTM) | $3.67B(TTM) |
| Earnings growth (YoY) | 23.0% | 56.7% |
| EPS, diluted | $8.72(TTM) | $2.47(TTM) |
| EBIT margin | 29.3% | 18.0% |
| ROE | 15.7% | 11.6% |
| ROIC | — | 10.0% |
| Piotroski F | — | 8/9 |
| 1y total return | -13.2% | -55.7% |
Figures from SEC filings · for reference only · not investment advice
Growth of $10,000: ISRG vs BSX
| Metric | ISRG | BSX |
|---|---|---|
| End value | $54.6K | $19.8K |
| Total return | +445.5% | +98.0% |
| CAGR | +17.8% | +6.8% |
| Volatility | 32.7% | 27.4% |
| Sharpe | 0.54 | 0.23 |
| Sortino | 0.78 | 0.31 |
| Max drawdown | -49.9% | -60.6% |
Based on 2600 common trading days, 2016-05-13 → 2026-09-16 · risk-free 4.11% (current short-Treasury, held constant)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)